OS 47720
Alternative Names: NXD-30020; OS-47720; Pochoxime CLatest Information Update: 28 Aug 2024
At a glance
- Originator OncoSynergy
- Class Antidementias; Neuroprotectants; Pentanones; Piperidines; Small molecules
- Mechanism of Action HSP90 heat-shock protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- No development reported Alzheimer's disease
Most Recent Events
- 28 Aug 2024 No recent reports of development identified for preclinical development in Alzheimer's-disease in USA (Intraperitoneal, Injection)
- 16 Jun 2023 Chemical structure information added
- 23 Jan 2023 OS 47720 is available for licensing as of 23 Jan 2023. https://oncosynergy.com/#learn-more